UAS Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,170
Closed -$1.88M 16
2024
Q2
$1.88M Buy
+13,170
New +$1.75M 0.45% 15
2024
Q1
Sell
-5,000
Closed -$517K 19
2023
Q4
$517K Buy
+5,000
New +$494K 0.13% 17

Other funds holding NVO

UAS Asset Management's NVO Position: Q3 2024 in Review

UAS Asset Management sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 13,170 shares — an estimated $1.88M sold.

UAS Asset Management first reported a position in NVO in Q4 2023 and held it in 2 quarters. The position peaked at $1.88M in Q2 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • UAS Asset Management reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • UAS Asset Management sold 13,170 Novo Nordisk shares in Q3 2024, an estimated $1.88M.
  • UAS Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 2 quarters.
  • UAS Asset Management's Novo Nordisk position peaked at $1.88M in Q2 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on UAS Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.